Panacea Life Sciences Holdings, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Panacea Life Sciences Holdings, Inc. (PLSH) had Deferred Tax Assets, Operating Loss Carryforwards of $3.85 million as of 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2022-03-31
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards $3.85M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $8.34M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.23M.
- 2018-12-31: Deferred Tax Assets, Operating Loss Carryforwards $2.19M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $2.67M.
- 2017-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.28M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2020-12-31 | $3.85M 10-K · filed 2022-03-31 | $8.34M 10-K · filed 2021-04-15 |
| 2019-12-31 | $4.23M 10-K/A · filed 2021-04-23 | |
| 2018-12-31 | $2.19M 10-K · filed 2020-05-22 | $2.67M 10-K · filed 2019-03-29 |
| 2017-12-31 | $1.28M 10-K · filed 2019-03-29 |